Navigation Links
irisnote Announces Successful Conclusion of Beta Test Phase
Date:4/3/2013

Redwood City, CA (PRWEB) April 03, 2013

irisnote today announced the successful conclusion of its beta test, which included over 2000 scientists and researchers in corporate, government and academic institutions. irisnote Cloud Edition, an online cloud-based Electronic Laboratory Notebook and intellectual property (IP) management service accelerates research by enabling scientists to document their work, collaborate with others, and ensure their IP is protected.

“At irisnote, we’re building a solution that allows researchers to enter their work where they want in the way they feel most comfortable. Every day research organizations come to us because current methods of maintaining valuable research are inadequate for the job,” said Peter Herz, CEO of irisnote. “irisnote enables scientists to quickly and easily document, manage and review their research. For example, with our new iPad app, notebook entries are totally free-form – users can type text, handwrite with character recognition, dictate, add files of any kind, edit entries, and then flip through their notebooks using intuitive gestures, just like they do when reading eBooks.”

irisnote is built upon a powerful 21 CFR Part 11 compliant ELN engine, ensuring the safety and security of user data. At the same time, irisnote allows users to easily share their work with their colleagues and peers, search for new colleagues with irisnote’s proprietary Find Experts feature, and collaborate in real time through our built-in, compliant messaging platform.

“irisnote’s new offerings provide a platform for the advancement of Scientific Resource Planning. Our new ELN offering is the core of the platform. Institutions the world over are finding that their most valuable asset – their research – is not well managed, protected or controlled,” said Craig Harper, CTO for irisnote. “Now there’s no longer a need for them to use ad-hoc, home-grown solutions that fail to safeguard their research and IP, that don’t allow them to securely collaborate with colleagues and peers, regardless of location. irisnote is the ELN, evolved.”

To get started, users should visit http://irisnote.com/go2reg to setup a free account. irisnote Cloud Edition supports Windows and Mac notebooks and desktops as well as iPad tablets.

irisnote Cloud Edition standard accounts are available free of charge and users can upgrade to a Premium account at any time. irisnote also offers a Private Cloud Edition – an on-premise solution for research organizations that require it.

About irisnote, Inc.
irisnote, Inc. provides a cloud based software solution to help organizations protect their R&D investments and increase collaboration and efficiency. The company serves a global base of commercial, academic, government and nonprofit research labs in biology and multidiscipline research areas. irisnote combines Electronic Lab Notebook (ELN) and scientific content management for a complete paperless lab information and record-keeping solution. See http://irisnote.com.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10595375.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
3. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
4. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
5. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
6. WuXi PharmaTech Announces Third-Quarter 2011 Results
7. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
8. Spherix Announces Third Quarter Financial Results
9. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
10. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
11. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS announces ... addition of its newest module, US Hemostats & Sealants. , SmartTRAK’s US Market ... hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. BioMedGPS ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... in its endogenous context, enabling overexpression experiments and avoiding the use of exogenous ... RNA guides is transformative for performing systematic gain-of-function studies. , This complement ...
(Date:10/11/2017)... , Oct. 11, 2017  VMS BioMarketing, a leading ... a nationwide oncology Clinical Nurse Educator (CNE) network, which will ... need for communication among health care professionals to enhance the ... nurses, office staff, and other health care professionals to help ... breast cancer. ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced ... to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B ... to cross the cell membrane and bind intracellular STAT3 and inhibit its function. ...
Breaking Biology Technology:
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ... appointment of independent Directors Mr. Robin D. Richards ... Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive ... their guidance and benefiting from their considerable expertise as we ...
(Date:4/5/2017)... Allen Institute for Cell Science today announces the launch ... dynamic digital window into the human cell. The website ... deep learning to create predictive models of cell organization, ... suite of powerful tools. The Allen Cell Explorer will ... resources created and shared by the Allen Institute for ...
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
Breaking Biology News(10 mins):